Overview
The pivot of the Life Sciences industry is shifting from cost optimization to innovative ways of bringing more drugs to market or even fail faster during the discovery and R&D stage. With advent of disruptive information technology (IT), this shift is more prominent in the rather conservative industry like ours. This conference aims to bring case studies and thought leadership on how IT can deliver better business outcomes which impact quintessential indicator of ‘speed to market’ aimed towards improved quality of outcome and enhanced regulatory compliance
Program Highlights
- Leveraging Digital Technologies to bring efficiencies in Clinical Operations
- IDMP Compliance need as well as Opportunities/ Impact on regulatory and safety
compliance - Convergence Digital
- TransCelerate’s Shared Investigator Platform (SIP) – An Update
- Clinical Data Disclosure and Transparency - Point of View
- Innovative approach to accelerate clinical trial
- Next Generation Regulatory Information Management System
- Conducting Trials in India : Challenges and Current Status
- Data Transformations challenges/ regulatory recommendations
- Convergence of Life sciences and health-care industry
- SaaS model in life-sciences and health-care
Featured
Want to learn more about Life Science IT Business Enabled Conference? You've come to the right site!
Program Committee
-
Arshad Mohammed Sr. Product Specialist Dir.
QuintilesIMS, United States -
Jayathirtha Gopalakrishna Principal Sales Consultant, Health Sciences Global Business Unit
Oracle Inc, United States -
Sanjeev Sachdeva Chief Technology Officer - Life Sciences
Tata Consultancy Services, India -
Shobhit Shrotriya, PMP Managing Director, Life Sciences R&D Operations, India
Accenture, India -
Siddharth Shah, MBA Client Service Executive
Cognizant, United States
Have an account?